CVS Health
-
CVS Health Revises Outlook, Showcases Business Strength, and Unveils Innovative Health‑Care Strategy at Investor Day
CVS Health outlined a growth plan that leverages its Aetna, Caremark, Pharmacy and Health‑Care Delivery businesses to deliver best‑in‑class execution, transform consumer experience and become the partner of choice. The company revised its full‑year 2025 financial guidance—revenues ≥ $400 bn, adjusted EPS $6.60‑$6.70—and provided initial 2026 targets, aiming for a mid‑teens adjusted EPS compound annual growth rate through 2028. CVS also launched an AI‑native “Engagement as a Service” platform to unify and simplify health‑care interactions across its ecosystem.
-
Aetna Achieves High Medicare Advantage Star Ratings for 2026
Aetna, a CVS Health company, announced strong performance in its Medicare Advantage (MA) plans, with over 81% of members in plans rated 4 stars or higher by CMS for 2026; over 63% are in 4.5-star plans. Several Aetna contracts have consistently maintained or improved their high star ratings, reflecting Aetna’s commitment to quality care and member satisfaction. These ratings are crucial for member choice and impact plan reimbursement rates. Aetna leverages technology and integrated care to enhance offerings.